Studies on a new 1, 5-benzothiazepine derivative (CRD-401). II. Vasodilator actions.
D000818:Animals; D000840:Anisoles / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D004155:Diphenhydramine / Q000494:pharmacology; D004285:Dogs; D005263:Femoral Artery / Q000187:drug effects; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D013237:Stereoisomerism; D014665:Vasodilator Agents
D000840:Anisoles; D001552:Benzazepines; D008744:Methylamines; D014665:Vasodilator Agents; D001285:Atropine; D004155:Diphenhydramine; D011433:Propranolol; D010208:Papaverine